Charting the research frontier for viral infections, immunomodulation, and dementia: a perspective on synaptic biomarkers as essential clinical trial endpoints

Chun Kiat Lee, Michael Woodward, Mark I Hohenberg, Julian W Tang

Open source

DOI
10.3389/fcimb.2025.1701760
Published
2026-01-05
Container
Frontiers in Cellular and Infection Microbiology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcimb.2025.1701760,
  title = {Charting the research frontier for viral infections, immunomodulation, and dementia: a perspective on synaptic biomarkers as essential clinical trial endpoints},
  author = {Chun Kiat Lee and Michael Woodward and Mark I Hohenberg and Julian W Tang},
  year = {2026},
  journal = {Frontiers in Cellular and Infection Microbiology},
  doi = {10.3389/fcimb.2025.1701760},
  url = {https://doi.org/10.3389/fcimb.2025.1701760}
}

RIS

TY  - JOUR
TI  - Charting the research frontier for viral infections, immunomodulation, and dementia: a perspective on synaptic biomarkers as essential clinical trial endpoints
AU  - Chun Kiat Lee
AU  - Michael Woodward
AU  - Mark I Hohenberg
AU  - Julian W Tang
PY  - 2026
JO  - Frontiers in Cellular and Infection Microbiology
DO  - 10.3389/fcimb.2025.1701760
UR  - https://doi.org/10.3389/fcimb.2025.1701760
ER  - 

APA

Lee, C. K., Woodward, M., Hohenberg, M. I., & Tang, J. W. (2026). Charting the research frontier for viral infections, immunomodulation, and dementia: a perspective on synaptic biomarkers as essential clinical trial endpoints. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1701760

Source records